News & Achievements
IntMedRheumKnightLabProgramUpdateREV2_0.png

Read the new APS Program Update that includes the lab's latest news and achievements, recent lectures and talks by our lab members, an update on the DARE-APS clinical trial, and What I'm Reading in APS Research, written by Dr. Jason Knight, who highlights publications relevant to APS from early 2024.

Join our APS Program email list.

February 2024            June 2022

December 2023          April 2022

October 2023             February 2022

August 2023               December 2021

June 2023                   October 2021

April 2023                   August 2021        

February 2023            June 2021

December 2022          April 2021

October 2022             February 2021            

August 2022   

 

Dr. Jason Knight discusses the connection between autoimmune conditions and blood clots in the Stop the Clot April PEP Talk with the National Blood Clot Alliance.

News
See All What Rheumatologists Need to Know About Antiphospholipid Syndrome
Research News
What Rheumatologists Need to Know About Antiphospholipid Syndrome
Dr. Ray Zuo and Dr. Jason Knight review the critical updates and practical insights a rheumatology professional should know about APS.
APS Research Labs
Research News
Calprotectin Shows Promise as APS Thrombocytopenia Biomarker
The APS Research Labs and colleagues evaluate the presence, clinical associations, and potential mechanistic roles of circulating calprotectin in a cohort of patients with primary APS and those with antiphospholipid antibodies.
aps_labs-research-zuo
Research News
Taubman Institute Appoints Three New Emerging Scholars
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
aps_labs
Research News
UMich researchers find potential treatment target for APS-related thrombocytopenia
UMich researchers find potential treatment target for APS-related thrombocytopenia
thumbnail_lra_lockuptag_1920x1080
Research News
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
vial of blood in container lab blue yellow grainy graphic
Health Lab
Unveiling potential diagnostic, treatment target for APS-related thrombocytopenia
Researchers at the University of Michigan Health have unveiled a new mechanism that drives thrombocytopenia and a potential clinically actionable biomarker for antiphospholipid syndrome associated thrombocytopenia.